HDAC7 promotes renal cancer progression by reprogramming branched-chain amino acid metabolism.

In the SN12-PM6-1 model, there was a trend toward reduced primary tumor growth with HDAC7 knockdown; however, these data did not reach statistical significance (fig.

also in 111,027 other papers